Black Diamond Therapeutics, Inc

Q2 2024 13F Holders

Symbol
BDTX
CUSIP
09203E105
Type
Equity
Class
COM
Num filings
100
Total reported value, excl. options
$219 M
Manager Report Date Value ($000) Shares Option Type